tlooto
Sign up

Bimiralisib. Phosphatidylinositol 3-kinase (PI3K)/mechanistic target of rapamycin (mTOR) inhibitor, Treatment of solid tumors, Treatment of lymphoma

F. Bertoni, C. Tarantelli

2023Drugs of the Future

DOI: 10.1358/dof.2023.48.3.3509749

Abstract

Abstract is not available.

Citation format

BERTONI, F.; TARANTELLI, C. Bimiralisib. phosphatidylinositol 3-kinase (pi3k)/mechanistic target of rapamycin (mtor) inhibitor, treatment of solid tumors, treatment of lymphoma. Drugs of the Future, 2023.